| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: there are offered: an anti-cancer combination formed by VEGF Trap inhibitor with irinotecan and therapeutically applicable in treating neoplastic diseases, and a product containing it. What is shown is synergic action of the combination in growth inhibition of colonic carcinoma.EFFECT: invention enables using the ingredients of the combination in lower doses vs those applicable separately, and increasing activity with reduced toxicity or inhibiting their manifestations.3 cl, 1 tbl |
